SAVE THE DATE

January 26 - 28, 2012

Hotel Nikko
San Francisco, CA

The FOURTH annual T-cell Lymphoma Forum is a 2½-day meeting focusing on the latest information on novel agents and treatment approaches. The Forum, cochaired by Francine M. Foss, MD, and Kensei Tobinai, MD, PhD, will provide a platform for discussion about the classification, epidemiology, prognosis, and pathogenesis of several T-cell lymphoma subtypes.

Drs Foss and Tobinai have developed a very comprehensive program intended to examine the differences in the presentation of the diseases and describe the clinical outcomes of treatment strategies, with an emphasis on novel and innovative treatment approaches.

Attendees will have the opportunity to interact with T-cell lymphoma experts from all over the world. Plan to join our distinguished international faculty for this informative program.

This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma.

We look forward to having you participate in what we anticipate will be a very stimulating program.

Abstract Submission Deadline EXTENDED to November 7, 2011.